Rilpivirine is well tolerated, and it was developed at a time when the alternative in its class was efavirenz, which set a low bar that rilpivirine comfortably cleared.
What happens in the first weeks?
Headache, nausea, disturbed sleep and abnormal dreams occur in a minority, generally mild and usually settling within two to four weeks.
How does it compare with efavirenz?
Considerably better. Rash, dizziness, abnormal dreams and other neuropsychiatric events were all substantially less frequent in the direct comparisons, and discontinuation for side effects was lower.
Does that mean they do not occur?
No. Sleep disturbance and abnormal dreams are still reported by a minority, usually milder and more likely to settle. They are worth mentioning if they persist beyond a month.
What about mood?
Depression and mood changes have been reported and appear in the product information. Any mood change after starting is worth raising rather than attributing to circumstances, since the timing is informative and alternatives exist.
What about rash?
Occurs in a minority and is usually mild, which distinguishes it from several older non-nucleosides. Any rash with fever, blistering, peeling skin, or involvement of the mouth or eyes is an emergency regardless of cause.
What about lipids?
Favourable. Cholesterol and triglycerides are generally better than on efavirenz or boosted protease inhibitors, and switching from those tends to improve them.
What about the liver?
Liver enzyme rises occur and are monitored, more commonly in people with hepatitis B or C. Yellowing of the eyes or skin, dark urine or pain under the right ribs warrant prompt contact.
What about heart rhythm?
At doses well above the licensed one, rilpivirine prolongs the QT interval. At 25mg this is not generally a concern, and caution applies for anyone with existing conduction problems or taking other drugs with the same effect.
What about the injection?
Injection site reactions dominate: pain, swelling and hardness lasting a few days, diminishing with successive injections. Fever, tiredness and muscle aches can follow in the days afterwards, particularly early on.
What about weight?
Reported changes have been modest compared with integrase inhibitors. For someone who has gained weight on an integrase-based regimen, this is a relevant point of comparison.
What about kidneys and bones?
Nothing attributable to rilpivirine. Where a combination contains tenofovir, the usual considerations for that component apply and require monitoring.
What if you cannot tell which component is responsible?
Frequently you cannot without changing something. A clinician can usually narrow it by pattern and timing, and switching one part of a combination is often possible.
Do side effects mean it is working?
No, and their absence does not mean it is not. There is no relationship between how you feel and how well the virus is suppressed. Blood tests are the only reliable measure.
What monitoring is there?
Blood tests every three to six months covering viral load, kidney and liver function and lipids. On the injectable regimen, appointments are more frequent, which makes monitoring easier to keep up with.
When should you contact your clinic?
Any rash with systemic symptoms, mood changes, anything lasting beyond a month, or anything making you consider stopping.
Should you look side effects up online?
The leaflet lists everything ever reported, which is alarming and unhelpful for judging likelihood. A clinic pharmacist will tell you which effects are common and which matter, in about two minutes.